Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity. - Leonard EK; Tomala J; Gould JR; Leff MI; Lin JX; Li P; Porter MJ; Johansen ER; Thompson L; Cao SD; Hou S; Henclova T; et al. (JCI insight, 2024)